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Growth of Salmonella inside infected host cells is a key aspect of their ability to cause local 9 
enteritis or systemic disease. This growth depends on exploitation of host nutrients through a 10 
large Salmonella metabolism network with hundreds of metabolites and enzymes. Studies in 11 
cell culture infection models are unraveling more and more of the underlying molecular and 12 
cellular mechanisms, but also show striking Salmonella metabolic plasticity depending on 13 
host cell line and experimental conditions. In vivo studies have revealed a qualitatively 14 
diverse, but quantitatively poor, host-Salmonella nutritional interface, which on one side 15 
makes Salmonella fitness largely resilient against metabolic perturbations, but on the other 16 
side severely limits Salmonella biomass generation and growth rates. This review discusses 17 
goals and techniques for studying Salmonella intracellular metabolism, summarizes main 18 





Salmonella enterica is a Gram-negative bacterium and a close relative of Escherichia coli. 22 
There are more than two 2300 different Salmonella serovars, many of which can cause local 23 
intestinal disease (enteritis, diarrhea) in a broad range of hosts. By contrast, some serovars 24 
can also disseminate from the gut and cause systemic disease in a host-specific manner 25 
(enteric fever / (para)typhoid fever, non-typhoidal salmonellosis NTS). Salmonella cause 26 
major mortality and morbidity worldwide (Havelaar et al., 2015, Keestra-Gounder et al., 27 
2015, LaRock et al., 2015, Wain et al., 2015). Vaccines for prevention of human disease are 28 
available for the single serovar Typhi, and have only moderate protective efficacy. 29 
Antimicrobial chemotherapy becomes less and less effective due to rapidly increasing 30 
multidrug resistance, and both the US Center for Disease Control and the WHO include 31 
Salmonella among the most serious infectious disease threats for human health. In addition to 32 
better vaccines and novel antibiotics, interference with transmission by supplying clean 33 
drinking water can dramatically reduce incidence of enteric fever, and better control of 34 
Salmonella carriage in animal livestock might largely prevent diarrheal disease and NTS.  35 
 There are two main types of Salmonella infection, causing either enteritis or systemic 36 
disease. Both infections start with ingestion of Salmonella-contaminated food or water. A 37 
large part of the ingested Salmonella are killed by stomach acid, bile, and intestinal defensins 38 
(Wotzka et al., 2017). Neutrophils migrating through the gut mucosa also efficiently kill 39 
Salmonella in the gut lumen, and neutrophils and macrophages in the gut mucosa kill 40 
efficiently invading Salmonella. Nevertheless, if the infectious dose is large enough (i.e, 41 
higher than 1’000 to 100’000 colony-forming units) and competition by resident microbiota 42 
is overcome, surviving Salmonella can overwhelm these defenses and cause disease in the 43 
intestine. During enteritis, Salmonella proliferates mostly in the gut lumen, although some 44 
Salmonella invade the intestinal mucosa and proliferate in gut epithelial cells (Wotzka et al., 45 
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2017), and this is strongly enhanced in neonate mice (Zhang et al., 2014). Intra-epithelial 46 
Salmonella proliferation leads to inflammasome activation and extrusion of infected cells 47 
(Knodler et al., 2014, Sellin et al., 2014, Zhang et al., 2014), which might contribute to the 48 
overall inflammation response which ultimately leads to water loss to the lumen and diarrhea 49 
(Darwin et al., 1999). However, the importance of this epithelial proliferation for enteritis 50 
pathology and Salmonella overall fitness and transmission is still unclear. 51 
Salmonella serovars that can cause systemic disease on the other hand, enter intestinal 52 
Peyer’s patches and solitary intestinal lymphoid tissue. In mouse models, Salmonella are 53 
rarely found in epithelial cells of adult hosts (Halle et al., 2007, Zhang et al., 2014), whereas 54 
in neonate mice, which largely lack differentiated M-cells, Salmonella mostly invade 55 
epithelial cells and probably disseminate from there to internal organs (Zhang et al., 2014). 56 
Just a few clones can successfully establish themselves in these tissues and disseminate 57 
systemically (Meynell, 1957, Lim et al., 2014). Within host tissues, Salmonella resides and 58 
proliferates predominantly in tissue macrophages but also other cell types (Burton et al., 59 
2014). Spleen and liver are major target organs but other tissues are also infected. From the 60 
liver, Salmonella can reach the gallbladder where they proliferate in gallbladder epithelial 61 
cells (and on gallstones, if present). Infected cells activate the inflammasome and are 62 
extruded (Knodler et al., 2010). Released Salmonella then reach together with bile the 63 
intestine and ultimately feces, thus closing the transmission cycle.  64 
Taken together, intracellular Salmonella proliferation occurs during both diarrheal and 65 
systemic disease. The metabolic conditions and mechanisms that drive this intracellular 66 
growth are the focus of extensive research efforts since a better overview of the Salmonella-67 
host metabolic landscape might open new windows for antimicrobial development. In this 68 
review, we discuss some aspects of this exciting field. Additional aspects are covered in other 69 
informative recent reviews     (Eisenreich et al., 2010, Dandekar et al., 2012, Eisenreich et 70 
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al., 2013, Dandekar et al., 2014, Eisenreich et al., 2015). For Salmonella metabolism during 71 
extracellular stages, an excellent review has recently been published (Rivera-Chavez et al., 72 
2015). 73 
  74 
Metabolism as a basis for Salmonella fitness, virulence, and persistence  75 
Salmonella in vivo proliferation requires de novo synthesis of biomass components such as 76 
proteins, carbohydrates, lipids and nucleic acids from small molecule precursors. Salmonella 77 
can obtain these precursors from internal storage such as glycogen or lipids (for a limited 78 
number of divisions) or directly from the host microenvironment (e.g., amino acids), and/or 79 
synthesize them from a few basic host carbon (such as acetate, glycerol, glucose), nitrogen 80 
(e.g., ammonium), sulfur (e.g., sulfate), and phosphor (e.g., phosphate) sources. How 81 
Salmonella salvages these nutrients from the host is still a matter of debate and will be 82 
discussed later on. Nutrient uptake and conversion into biomass requires substantial energy, 83 
and finding and exploiting a suitable energy source is the single most important metabolic 84 
activity of growing cells (Abu Kwaik et al., 2015). Counterintuitively, Salmonella seems to 85 
diminish ATP production under some host conditions by direct inhibition of the ATP 86 
synthase with MgtC (Lee et al., 2013), a protein that is required for wild-type level 87 
Salmonella fitness (Alix et al., 2008). This could be a special adaptation to limiting 88 
magnesium availability by releasing ATP-bound magnesium for ribosome stabilization 89 
(Pontes et al., 2016). 90 
 Nutrient availability and Salmonella metabolic capabilities will modulate overall 91 
biomass generation and proliferation (Monahan et al., 2016) and thus Salmonella fitness in 92 
host tissues during infection. Identifying and quantifying relevant nutrients as well as the 93 
corresponding catabolic and anabolic Salmonella pathways is therefore of fundamental 94 
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importance for understanding the disease process and to identify opportunities for specific 95 
enzyme inhibitors as urgently needed novel antimicrobials to control infection. Moreover, 96 
Salmonella metabolic mutants might be useful as live attenuated vaccines (Tennant et al., 97 
2015), or as cancer therapeutics (Wang et al., 2016).  98 
 It is important to note that fitness (the capability to produce viable offspring) does not 99 
always correlate with virulence (the capability to cause host pathology). Indeed, Salmonella 100 
mutants with severe fitness defects nevertheless still cause wild-type level gut pathology in 101 
single-strain infections in the mouse enteritis model (Winter et al., 2010, Thiennimitr et al., 102 
2011, Faber et al., 2017). Inhibiting the corresponding enzymes would thus have limited 103 
impact on disease progression. By contrast, several metabolic mutations (galE, purA, aroA, 104 
aroCD, manA, etc.) abrogate both Salmonella in vivo fitness as well as systemic virulence in 105 
the mouse typhoid fever model and in human volunteers (Bumann et al., 2000), highlighting 106 
metabolism as a key targetable aspect of systemic salmonellosis.  107 
 Metabolism is not only required for proliferation but also for maintaining essential 108 
basal activities even in non-dividing Salmonella cells. Identification of such “dormancy”-109 
associated metabolic activities could provide a basis for specific targeting of Salmonella 110 
persisters that can survive even prolonged antimicrobial chemotherapy (Harms et al., 2016). 111 
However, such pathways seem to be quite rare with the possible exception of fatty acid 112 
biosynthesis (Barat et al., 2012). 113 
Finally, Salmonella metabolic enzymes might be important for disease progression 114 
not because of their catalytic activity, but rather due to unrelated so-called moonlighting 115 
functions (Henderson, 2014). So far, there is only one example of such a moonlighting 116 
enzyme with a role in Salmonella virulence (the sugar transport protein and metabolic 117 
regulator EIIAGlc that activates the second type 3 secretion system encoded on Salmonella 118 
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pathogenicity island 2, (Maze et al., 2014). It is possible that additional enzymes have 119 
relevant moonlighting functions as is the case for other pathogens (Henderson, 2014), and 120 
this is an important caveat for “simple” metabolic interpretations of enzyme defect 121 
phenotypes. 122 
 123 
Goals for studying intracellular Salmonella metabolism 124 
One of the major challenges in studying Salmonella in vivo metabolism and identifying 125 
potential antimicrobial targets is the strong interplay between Salmonella and the mammalian 126 
host cells, which provide a very complex metabolic microenvironment for intracellular 127 
Salmonella. These host cells contain thousands of different metabolites and use versatile 128 
regulatory mechanisms to modulate metabolite concentrations and metabolic fluxes. 129 
Furthermore, they can dramatically alter their metabolism in various cell differentiation and 130 
activation states which strongly influences nutrient availability and hence Salmonella fitness. 131 
The interplay works in both directions, with the host cell providing nutrients for Salmonella, 132 
and Salmonella simultaneously perturbing the host metabolic network by consuming certain 133 
metabolites and releasing waste products (Olive et al., 2016).  134 
In addition to these direct interactions, Salmonella releases waste products, produces 135 
stimulatory components such as lipopolysaccharide, and secretes numerous virulence factors 136 
directly into the host cell cytosol. These Salmonella activities modulate host cell physiology 137 
in a wide variety of aspects including host cell synthesis of toxic molecules that affect 138 
Salmonella metabolism. This includes nitric oxide, which can block respiration (Husain et al., 139 
2008); itaconic acid, which inhibits the glyoxylate shunt (Michelucci et al., 2013); and 140 
superoxide/peroxide that damages several bacterial components whose repair requires 141 
supportive metabolism (Slauch, 2011, Burton et al., 2014). Importantly, many of these host / 142 
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Salmonella interactions are highly heterogeneous with strong cell-to-cell variation on both 143 
the host cell and the Salmonella side (Helaine et al., 2014b, Bumann, 2015, Knodler, 2015, 144 
Kreibich et al., 2015, Mills et al., 2017, Saliba et al., 2017). 145 
To understand how this complex and changing metabolic landscape supports and/or 146 
limits Salmonella fitness, we need to address the following questions: (i) which nutrients are 147 
available for intracellular Salmonella, and which host cell supply routes ensure sufficient 148 
replacement of consumed nutrients? (ii) which pathways do Salmonella employ to utilize 149 
these nutrients for energy production and biomass generation, and to what extent can 150 
Salmonella compensate for perturbations of these processes by employing alternative, 151 
partially redundant pathways? (iii) what are the consequences for host cell physiology and 152 
metabolism? (iv) what is the level of heterogeneity in host and Salmonella metabolism, and 153 
are there particularly important subsets with unusual properties? 154 
 155 
Methods for investigating intracellular Salmonella metabolism 156 
The most direct experimental technique to monitor host and Salmonella metabolism is 157 
metabolomics, which can reveal both metabolite concentrations and metabolic fluxes 158 
(Zampieri et al., 2017). Infected cells contain both host and Salmonella metabolites, and 159 
available separation techniques are too slow compared to the turnover rates for most 160 
metabolites, making assignment difficult (except for a few kingdom-specific metabolites such 161 
as peptidoglycan and lipid precursors, and secondary metabolites). Mass imaging techniques 162 
might offer a solution, but spatial resolution is still insufficient for distinguishing intracellular 163 
Salmonella from surrounding host cell contents (Petras et al., 2017).  164 
Even if we could determine metabolite concentrations in Salmonella and their 165 
microenvironment, such data would not necessarily reflect their relative importance. 166 
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Nutrients might be present at low concentration but still have high turnover rates with 167 
vigorous Salmonella salvage and rapid host replenishment, resulting in an important 168 
contribution to Salmonella fitness. Instead of metabolite concentrations, metabolic fluxes are 169 
therefore more relevant. To obtain such data, one can follow the fate of isotope-labelled 170 
glucose and the incorporation of each atom into various amino acids (that are stably retained 171 
as part of proteins) (Sauer, 2006, Eisenreich et al., 2015). Amino acid labeling patterns reflect 172 
their origin at various central carbon metabolism intermediates, enabling the reconstruction of 173 
major fluxes in these central pathways. Interpretation of results for intracellular Salmonella 174 
can be complicated due to direct transfer of labeled host amino acids into Salmonella (Gotz et 175 
al., 2010). Such approaches mostly focus on incorporation of 13C and/or 15N isotope labels 176 
into Salmonella biomass. In addition, it can be useful to detect waste products generated by 177 
fundamentally important energy conversion pathways in the cell culture medium (Kentner et 178 
al., 2014, Garcia-Gutierrez et al., 2016). All these techniques might be also applicable for in 179 
vivo analysis as Salmonella can be purified from infected host tissues using flow cytometry 180 
(Becker et al., 2006, Steeb et al., 2013). Data interpretation will need to take into account the 181 
increased complexity of whole organism metabolism of labeled nutrients. An exciting recent 182 
study tracked incorporation of deuterium-labelled drinking water of Leishmania-infected 183 
mice into macromolecules of the parasites (Kloehn et al., 2015).  184 
Complementary information can be obtained from enzyme proteomics. A general 185 
finding from various studies has been the large number and high expression levels of many 186 
metabolic enzymes indicating substantial Salmonella resource allocation into metabolism. 187 
Absolute quantification yields enzyme copy numbers per Salmonella cell (Steeb et al., 2013). 188 
Combination with tabulated turnover numbers kcat yields maximal reaction rates vmax for 189 
hundreds of metabolic conversions providing large-scale information on feasible metabolic 190 
pathways activities (Steeb et al., 2013, Schubert et al., 2015). Interpretation of such data is, 191 
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however, complicated by the fact that many enzymes have broader substrate spectrum 192 
besides their normally considered specificities (“substrate promiscuity”, e.g., pentoses in 193 
addition to hexoses) (Khersonsky et al., 2010). In some cases, such secondary reactions 194 
might be actually more relevant. Furthermore, a substantial fraction of metabolic reactions is 195 
non-enzymatic, and protein data thus can offer only incomplete coverage of metabolic 196 
networks (Keller et al., 2015). 197 
An additional layer of complexity is provided by the observation that the majority of 198 
metabolic reactions are dispensable for Salmonella fitness, since alternative pathways and 199 
supplementation by host metabolites often provide partial redundancy, or pathway products 200 
are not required (Becker et al., 2006, Bumann, 2009, Steeb et al., 2013). Several genome-201 
scale genetic screens and numerous more focused studies have revealed a few metabolic 202 
mutations with severe phenotypes. This may indicate true pathway relevance, or artefacts 203 
such as toxicity of truncated gene products, polar effects on downstream genes, or in 204 
particular accumulation of toxic upstream intermediates. Such artefacts can be minimized by 205 
clean deletion of genes encoding enzymes at metabolism branching points that lead into the 206 
pathway of interest (“first committed step”), with other branches buffering potential buildup 207 
of toxic precursors. Access to essential biomass precursors can be inferred from auxotrophic 208 
strains that depend on external supplementation. Interpretation should consider wasteful 209 
Salmonella degradation of such precursors (e.g. dispensable Salmonella lysine decarboxylase, 210 
which lowers lysine availability below biomass needs (Steeb et al., 2013)). Another 211 
complication could be moonlighting functions (see above). Single mutants can only identify 212 
non-redundant pathways. To determine the relevance of much more frequent partially 213 
redundant pathways, multiple mutations must be combined, and epistasis can provide further 214 
insights into pathway architecture (Ideker et al., 2012).  215 
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Understanding the metabolism network underlying Salmonella fitness during 216 
infection requires genome-scale integration of all complementary data sets. The consensus in 217 
silico reconstruction of Salmonella metabolism that was obtained in a jamboree involving 218 
more than fifty researchers provides a suitable basis for this (Thiele et al., 2011). It accounts 219 
for 1270 metabolic genes, 2201 metabolic reactions that were curated for thermodynamically 220 
feasible reversibility, and 1110 metabolites. This reconstruction reveals all known metabolic 221 
pathways and their interconnectivity as a basis for studying the entire Salmonella metabolism 222 
network in different external conditions and internal states.  223 
The substantial progress in understanding intracellular Salmonella metabolism is 224 
encouraging but one crucial, previously neglected aspect is just emerging. All experimental 225 
and in silico methods are based on population averages, but recent work has shown extensive 226 
heterogeneity between infected host cells and individual Salmonella cells in terms of 227 
microenvironments, stress, gene expression, overall metabolic activities, growth rates, and 228 
cell fates (Helaine et al., 2014b, Bumann, 2015, Knodler, 2015, Kreibich et al., 2015, Mills et 229 
al., 2017, Saliba et al., 2017). Differential nutrient access seems to cause heterogeneous 230 
Salmonella growth rates during systemic infection in vivo, with important consequences for 231 
disease progression and tolerance against antimicrobial chemotherapy (Claudi et al., 2014). 232 
New approaches for Salmonella single-cell and subpopulation analysis will be needed to 233 
unravel this fascinating new aspect of host-Salmonella interactions. 234 
 235 
Metabolic patterns of intracellular Salmonella in in vitro cell culture models 236 
Salmonella metabolism in cell culture infections has been covered in excellent recent reviews 237 
(Dandekar et al., 2014, Eisenreich et al., 2015), and we just summarize some findings here. 238 
Cell culture infections recapitulate a central hallmark of salmonellosis, intracellular 239 
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Salmonella replication in host cells. Compared to in vivo studies, cell culture infections 240 
enable detailed experimental analysis with a broad spectrum of techniques. Cell culture 241 
conditions such as medium composition and oxygen tension can be freely adjusted according 242 
to the specific research questions, and defined pulses of isotopically labeled nutrients enable 243 
tracking of the kinetics of metabolite conversion in both host and Salmonella cells. Another 244 
advantage is the focus on a single host cell type simplifying analysis and interpretation of 245 
results compared to complex in vivo situations.  246 
The results obtained so far indicate a major role of glucose as carbon/energy source, 247 
under some, but not all experimental conditions (Bowden et al., 2009, Holzer et al., 2012, 248 
Steeb et al., 2013, Bowden et al., 2014, Dandekar et al., 2014, Eisenreich et al., 2015, Popp 249 
et al., 2015, Garcia-Gutierrez et al., 2016, Liu et al., 2017, Singh et al., 2017). Peptides/ 250 
amino acids (Popp et al., 2015, Singh et al., 2017) and other nutrients such as C3 (pyruvate 251 
and/or glycerol) or C2 (acetate and/or fatty acids) metabolites (Gotz et al., 2010) are also 252 
available to intracellular Salmonella. Salmonella degrades these nutrients with its central 253 
carbon metabolism pathways such as glycolysis (Bowden et al., 2014, Garcia-Gutierrez et al., 254 
2016) and the TCA cycle (Bowden et al., 2010), and uses various intermediates of these 255 
pathways to synthesize several amino acids in addition to amino acids obtained from the host 256 
cell (Gotz et al., 2010). However, results have been quite diverse depending on specific host 257 
cells and conditions (Fig. 1A). Clarification of the most relevant setting should be a priority 258 
of future work (see below). 259 
Salmonella can also directly modulate host amino acid abundance. Salmonella 260 
catabolism of host asparagine causes T cell suppression in vitro, but has no detectable impact 261 
in vivo (Kullas et al., 2012), suggesting other reasons for fitness contributions of Salmonella 262 
asparagine catabolism (Jelsbak et al., 2014). Salmonella induces host arginase II expression 263 
(Lahiri et al., 2008), in addition to “stealing” of host arginine by ArgT-mediated uptake (Das 264 
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et al., 2010). Both processes could deprive host cells of a precursor for generating 265 
antimicrobial nitric oxide, but Salmonella subsets experience substantial nitric oxide levels 266 
during infection (Burton et al., 2014) suggesting sufficient arginine availability. Moreover, 267 
Salmonella arginine deiminase contributes to in vivo fitness without affecting host nitric 268 
oxide production (Choi et al., 2012), and arginine seems to serve as Salmonella 269 
carbon/nitrogen source (Steeb et al., 2013).  Salmonella also induces host tryptophan 270 
catabolites with immunomodulatory properties in the bloodstream of humans and mice 271 
(Blohmke et al., 2016). 272 
One major question is how the host supplies nutrients for intracellular Salmonella 273 
(Fig. 1B). One fascinating mechanism could be the formation of a large membrane network 274 
called Salmonella-induce filaments (Sif) (Liss et al., 2017). Salmonella can induce Sif with 275 
effector proteins that it injects into the host cell cytosol using the type 3 secretion system 276 
encoded on Salmonella pathogenicity island 2 (SPI-2). Sif continuously merge with 277 
endosomes providing a gateway between extracellular metabolites, which the host cell takes 278 
up by pinocytosis, and the Salmonella-containing vacuole (Drecktrah et al., 2007, Liss et al., 279 
2017). Indeed, this can be the major nutrient delivery pipeline for driving intracellular 280 
Salmonella growth (Holzer et al., 2012, Liss et al., 2017). An additional host cell nutrient 281 
supply pathway is chaperone-mediated autophagy providing peptides directly to the 282 
Salmonella-containing vacuole (Singh et al., 2017), which works independently of any 283 
extracellular nutrient supply.  284 
 285 
Future goals for in vitro cell culture studies 286 
An important goal is to define meaningful criteria for in vitro cell culture conditions that 287 
reproduce key aspects of host-Salmonella interactions during salmonellosis. Recent studies 288 
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have revealed dramatic differences in Salmonella metabolism and virulence mechanisms 289 
depending on particular host cell types and experimental conditions, and it remains often 290 
unclear which patterns are most pertinent for understanding actual disease processes.  291 
Most studies used cancer cell lines that are easy to cultivate and grow, and are 292 
permissive for Salmonella proliferation. However, compared to primary cells these cancer 293 
cells have distorted metabolism (respiration/fermentation, pentose pathway, lipid 294 
biosynthesis/β-oxidation, etc.) (Pavlova et al., 2016), which might affect the metabolism of 295 
intracellular Salmonella. The major model for epithelial cell infections are HeLa cells that are 296 
cervix carcinoma cells carrying the Human Papilloma virus 18 genome. Salmonella infection 297 
biology in HeLa cells differs in important aspects from (possibly more relevant) polarized 298 
epithelial cells, even when compared under identical conditions (Fig. 1A). This includes 299 
differential overall growth rates; relevance of glucose and other nutrients; divergent roles of 300 
glycolysis, overflow metabolism leading to acetate secretion, purine biosynthesis, chorismate 301 
biosynthesis (a key pathway for classifying biosafety of Salmonella mutants); and 302 
essentiality/dispensability of Sif formation (Holzer et al., 2012, Bowden et al., 2014, 303 
Lorkowski et al., 2014, Popp et al., 2015, Garcia-Gutierrez et al., 2016, Liu et al., 2017, 304 
Singh et al., 2017).  305 
Similarly, Salmonella metabolism and virulence mechanisms show remarkable 306 
differences depending on the macrophage activation status and source of host cells (cancer 307 
cell lines, primary bone marrow-derived macrophages) (Fig. 1A). Examples include the 308 
differential relevance of glucose for Salmonella nutrition; divergent roles of Salmonella TCA 309 
cycle and overflow metabolism; and differential requirements for Sif (Bowden et al., 2009, 310 
Lathrop et al., 2015, Popp et al., 2015, Garcia-Gutierrez et al., 2016) and extracellular small 311 
metabolites that could be supplied via Sif (Singh et al., 2017). Interestingly, one study 312 
suggested that SPI-2 and its role in Sif formation are actually dispensable for intracellular 313 
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growth in phagocytes in vivo. Instead, SPI-2 seems to play a major role in Salmonella cell-to-314 
cell spreading within host tissues (Grant et al., 2012), which is not the focus of most in vitro 315 
cell culture studies although it is an essential part of Salmonella in vivo fitness. Another 316 
particularly concerning discrepancy is the apparent dispensability of Salmonella respiration 317 
for growth in macrophages in vitro (Garcia-Gutierrez et al., 2016), whereas aerobic 318 
respiration is one of the key metabolic activities supporting Salmonella fitness in vivo 319 
(Turner et al., 2003, Steeb et al., 2013).  320 
Another caveat concerning in vitro Salmonella studies is the common use of cell 321 
culture media that contain non-physiological metabolite concentrations, which might affect 322 
both host cell and intracellular Salmonella metabolism. Intestinal epithelial cells (enterocytes) 323 
that are one important infected host cell type in vivo, do for example not normally depend on 324 
glucose but rather on microbiota-derived short-chain fatty acids as energy source although 325 
this can change during gut dysbiosis (Rivera-Chavez et al., 2016). 326 
To deal with this complexity and to ensure that the results are meaningful for 327 
understanding disease mechanisms in salmonellosis, we propose to derive a couple of 328 
decisive benchmarks from in vivo studies, and to use these benchmarks for establishment of 329 
appropriate in vitro cell culture models. As an example, Salmonella fitness in macrophage 330 
cell cultures should depend on respiratory pathways as it does in vivo. Glucose should 331 
contribute as a carbon and energy source, but only as one limited contribution among several 332 
nutrients (Bowden et al., 2009, Steeb et al., 2013) (whereas it could be more relevant during 333 
chronic infections (Eisele et al., 2013)). Benchmarks for metabolic pathways relevant for 334 
Salmonella fitness in epithelial cells in vivo are still largely lacking, but their establishment 335 
could be straightforward with Salmonella mutants in the mouse enteritis and/or neonate 336 
infection models. In particular, the role of central metabolic pathways and host cell processes 337 
such as Sif formation or chaperone-activated autophagy should be clarified in vivo. Once 338 
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such criteria are established, host cell types and culture conditions could be optimized in an 339 
iterative manner until key aspects of Salmonella intracellular metabolism in vivo are 340 
faithfully reproduced in vitro. A final step could be to reproduce the intracellular 341 
environment, and Salmonella exploitation of accessible nutrients as well as defense against 342 
toxic molecules, in axenic cultures (without any host cell). This would be particularly useful 343 
for screening of novel antimicrobials under meaningful conditions.  344 
A second focus of future studies of Salmonella in vitro cell culture infection models 345 
should be on heterogeneity. Most previous investigations have determined average properties, 346 
but recent studies clearly revealed striking differences between individual Salmonella cells 347 
but also substantial cell-to-cell variation among host cells. Salmonella subsets with divergent 348 
growth rates and metabolic activities exist in infected macrophages (Helaine et al., 2010, 349 
Claudi et al., 2014, Helaine et al., 2014a, Diacovich et al., 2016), and properties and fates of 350 
individual Salmonella-infected macrophages also highly variable (Avraham et al., 2015, 351 
Saliba et al., 2016, Thurston et al., 2016, McQuate et al., 2017). Striking heterogeneity has 352 
also been observed in epithelial HeLa cells. Most Salmonella remain initially in phagosomes 353 
where they slowly proliferate, but some Salmonella escape to the host cell cytosol where they 354 
can vigorously proliferate and overgrow the phagosomal Salmonella subpopulation, (Knodler 355 
et al., 2010, Knodler, 2015). While their differential growth rates must correspond to striking 356 
differences in biomass generation and the entire metabolism network (Knodler et al., 2010, 357 
Knodler, 2015, Wrande et al., 2016), and recent evidence reveals distinct gene expression 358 
patterns and genetic determinants for the two subpopulations (Knodler et al., 2010, Knodler, 359 
2015, Wrande et al., 2016), most HeLa infection studies merely determined average 360 
properties. Such data initially reflect mostly phagosomal Salmonella, but later predominantly 361 
the overgrowing cytosolic Salmonella subset. Consequently, data for early time points largely 362 
ignore the properties of a nevertheless particularly important Salmonella subset (the cytosolic 363 
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escapers), and differences along the time course could be misinterpreted as changing 364 
metabolic patterns of Salmonella cells, instead of changing contributions of two distinct 365 
subsets. It is possible that cytosolic Salmonella resemble cytosolic Shigella, which rely on 366 
conversion of host-derived pyruvate to acetate as the major energy conversion pathway 367 
(Kentner et al., 2014). In particular, Salmonella can grow even without glycolysis in these 368 
cells, excretes large amounts of acetate, and partially depends on acetyl-CoA to acetate 369 
conversion (Bowden et al., 2014, Garcia-Gutierrez et al., 2016, Liu et al., 2017). 370 
Traditional bulk average read-outs neglect this heterogeneity and could thus result in 371 
misleading interpretations. Single-cell approaches increasingly unravel the molecular 372 
differences between Salmonella and host cell subsets, but the corresponding metabolic 373 
patterns are still largely unknown.  374 
 375 
Salmonella metabolism during systemic infections 376 
In vivo models reflect relevant conditions during salmonellosis compared to more ambiguous 377 
cell culture conditions. For practical reasons most studies used a typhoid fever model of 378 
systemic salmonellosis in genetically susceptible mice. This model differs in some important 379 
aspects from human systemic salmonellosis (Santos et al., 2001), but the limited available 380 
information suggests at least similarities in Salmonella metabolism as compared to 381 
genetically resistant mice (Steeb et al., 2013) and human volunteers immunized with 382 
attenuated Salmonella enterica serovar Typhi (Bumann et al., 2000). A major drawback of in 383 
vivo studies is the severely restricted number of suitable experimental methods for 384 
investigating metabolism, and the much higher complexity of the host microenvironment 385 
with multiple cell types and strong inflammation dynamics. Under these circumstances, there 386 
are at present essentially only two applicable methods to study Salmonella metabolism; 387 
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proteomics to determine enzyme copy numbers, and competitive infections to determine 388 
fitness defects of metabolic mutants. On the other hand, contributions of many research 389 
groups over more than three decades have accumulated an astonishing amount of information 390 
that enabled us to derive a genome-scale metabolic reconstruction of Salmonella metabolism 391 
in infected mouse spleen (Steeb et al., 2013) (Fig. 2). Subsequent publications corrected 392 
some aspects (hydrogen oxidation not required  (Maier et al., 2013, Maier et al., 2014); 393 
reconsideration of proline biosynthesis mutants for inferring limited proline availability (Lee 394 
et al., 2014); contribution of asparagine deamination and polyamine synthesis for Salmonella 395 
fitness (Jelsbak et al., 2014)). However, this did not have much impact on the overall 396 
properties of the Salmonella metabolism network in vivo. 397 
 One striking finding is the large complexity of the in vivo host-Salmonella nutritional 398 
interface (Fig. 2). Salmonella has access to more than fifty diverse host nutrients comprising 399 
multiple carbon/energy and nitrogen sources, all amino acids (with limiting amounts for 400 
proline), many provitamins, and inorganic nutrients. Although an individual nutrient, 401 
glycerol, plays a key role, the broad availability of many different nutrients makes 402 
Salmonella metabolism largely resilient against perturbations. This in part explains the 403 
seemingly paradoxical finding that Salmonella invests major resources into metabolic 404 
enzymes suggesting a crucial importance of metabolism for Salmonella fitness in vivo, yet 405 
only few metabolic mutations show remarkable infection phenotypes (Becker et al., 2006, 406 
Bumann, 2009, Steeb et al., 2013). Many other microbial pathogens likely have access to 407 
similar complex host nutrients based on widespread auxotrophies for amino acids, 408 
nucleosides, and (pro)vitamins (Steeb et al., 2013).  409 
Salmonella degrades many of these nutrients primarily through the Embden-Meyerhof 410 
pathway (and to some extent also pentose-phosphate and Entner-Doudoroff), followed by the 411 
TCA cycle coupled with aerobic respiration involving ubiquinone as the main energy 412 
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providing pathway. Anaerobic respiration is dispensable (Craig et al., 2013) although 413 
Salmonella expresses several enzymes that could mediate such energy conversion pathways 414 
in vivo (Steeb et al., 2013). Vulnerable “Achilles heels” are rare in Salmonella metabolism 415 
and are almost entirely restricted to biosynthesis of essential biomass components that are not 416 
provided in sufficient amounts, or not at all, by the host such as peptidoglycan, riboflavin, 417 
unsaturated fatty acids, ubiquinone, etc. (Becker et al., 2006, Bumann, 2009, Steeb et al., 418 
2013).  419 
 As discussed above, Salmonella has access to a wide variety of different host-420 
nutrients. However, this does not necessary imply favorable conditions as available amounts 421 
could be still scarce. Quantitative simulation of the entire Salmonella metabolic network 422 
based on all available experimental data indeed suggested a severe overall nutrient limitation 423 
of Salmonella growth, suggesting that although the host microenvironment is qualitatively 424 
rich (providing many different nutrients), it is quantitatively poor (nutrients are available in 425 
only scarce amounts) resulting in slow growth with an average generation time around 6 h 426 
(Becker et al., 2006, Claudi et al., 2014).  427 
 Salmonella metabolism does not only depend on nutrient access. Host cells can also 428 
attack Salmonella with toxic molecules such as nitric oxide and reactive oxygen species 429 
(ROS), that could interfere with Salmonella metabolism and consume reducing equivalents 430 
for detoxification and repair. Nitric oxide can block Salmonella respiration (Husain et al., 431 
2008), but exposed Salmonella upregulate the detoxifying enzyme NO dioxygenase HmpA 432 
which lowers nitric oxide levels sufficiently to prevent fitness defects (Burton et al., 2014). 433 
Similarly, Salmonella that are exposed to moderate levels of reactive oxygen species in 434 
resident macrophages, upregulate catalases and peroxidases that together with generally 435 
expressed superoxide dismutase ensure uncompromised fitness (Burton et al., 2014). By 436 
contrast, neutrophils attack Salmonella with much higher levels of ROS that overwhelm 437 
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Salmonella defenses (Burton et al., 2014, Schurmann et al., 2017). Both Salmonella defenses 438 
against nitric oxide and ROS require reducing equivalents but this puts only small additional 439 
demands on Salmonella metabolism (in the range of 10% of total electron flow). Activated 440 
macrophages also express cis-aconitate decarboxylase (Irg1) (Michelucci et al., 2013), which 441 
produces itaconate. Itaconate could inhibit the Salmonella glyoxylate shunt, but 442 
concentrations are probably too low for fitness impairment, especially since Salmonella does 443 
not depend on the glyoxylate shunt during acute infections (Fang et al., 2005, Kim et al., 444 
2006). On the other hand, itaconate also inhibits host succinate dehydrogenase resulting in 445 
succinate accumulation, which increases inflammatory responses (Cordes et al., 2016) and 446 
modulates host fatty acid metabolism and ROS production (Hall et al., 2013). 447 
 As might be expected from the striking variation among both Salmonella and infected 448 
host cells in vitro (see above), Salmonella growth and metabolism is also highly 449 
heterogeneous in vivo (Claudi et al., 2014, Helaine et al., 2014a, Bumann, 2015). This is in 450 
part a consequence of differential stress conditions and Salmonella toxin expression, but 451 
varying access to host nutrients and inhomogeneous activities across the entire Salmonella 452 
metabolism network are also involved. The individual relevance of the many metabolic 453 
difference is still largely unclear, but growth patterns of a purine auxotrophic mutant indicate 454 
divergent Salmonella access to purines in vivo. Interestingly, nutrient access seems to be 455 
rather homogeneous within one Salmonella microcolony in one host cell, but can be very 456 
different in neighboring host cells suggesting that host cell properties might modulate nutrient 457 
supply (Claudi et al., 2014). 458 
  459 
Future goals for in vivo studies 460 
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A better understanding of heterogeneous Salmonella metabolism is clearly required to 461 
unravel host and Salmonella molecular mechanisms that enable rapid growth of some 462 
Salmonella subsets driving disease progression, but cause only slow to moderate growth of 463 
other subsets which enables these Salmonella cells to tolerate antibiotics exposure (Claudi et 464 
al., 2014). New single-cell techniques will be required to characterize qualitative and 465 
quantitative differences in nutrient access and metabolic pathway activities in the various 466 
Salmonella subsets. Apart from growth rate, other aspects of metabolism could also influence 467 
antimicrobial susceptibility and tolerance, and this could be highly relevant for explaining the 468 
surprisingly slow Salmonella eradication from infected mice and humans (Waddington et al., 469 
2014, Dobinson et al., 2017) with antibiotics that are highly effective against Salmonella in 470 
vitro.  471 
 Finally, a major enigma is still the mechanism of host nutrient delivery to intracellular 472 
Salmonella. Elegant in vitro studies suggest a major role in SPI-2 inducing Sif that connect 473 
the extracellular fluid to the Salmonella-containing vacuole (Liss et al., 2017). However, 474 
nutrients that actually reach Salmonella in vivo do not show a typical signature of blood 475 
metabolites but rather suggest predominant nutrient release by degradation of host 476 
macromolecules (Steeb et al., 2013), as would occur in lysosomes or autophagosomes. 477 
Moreover, one study challenges the role of SPI-2 (and therefore Sif) for intracellular 478 
Salmonella growth in vivo (Grant et al., 2012). Further work might (i) determine the in vivo 479 
occurrence of Sif around Salmonella-containing vacuoles in macrophages, (ii) determine 480 
nutrient access in Salmonella wild-type and SPI-2 mutants, and (iii) clarify the importance of 481 
vesicular trafficking and alternative mechanisms for nutrient delivery to the Salmonella-482 
containing vacuoles. Another very recent study proposes that host cell chaperone-mediated 483 
autophagy provides peptides (and possibly other host macromolecule degradation products) 484 
directly to the Salmonella-containing vacuole (Singh et al., 2017). Although this supply route 485 
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appears to have limited relevance for fitness of wild-type Salmonella in vitro cell culture 486 
infections (in contrast to a peptide-dependent mutant), this mechanism might still play a role 487 
in vivo. Methods that have been established to purify and analyze the phagosomal membrane 488 
from in vitro infected cells (Herweg et al., 2015, Vorwerk et al., 2015), might be applicable 489 
to in vivo conditions to obtain informative comprehensive data on suitable marker proteins 490 
(in addition to immunohistochemistry data) to address these issues.  491 
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Figure 1: Evidence for core Salmonella metabolic activities and nutrient supply routes.  792 
29 
 
A) Experimental evidence for Salmonella intracellular metabolism in various cell culture 793 
models and during systemic salmonellosis in the mouse typhoid fever model. Data for 794 
intracellular growth, glucose as a major nutrient, key metabolic pathways (EMP, Embden-795 
Meyerhof-Parnas pathway; TCA, tricarboxylic acid cycle; Aerob Resp, aerobic respiration), 796 
and the role of Salmonella-induced filamens (Sif) for nutrient supply are shown (++, strong 797 
effect; 1, significant but moderate effect, -, no detectable impact; --, growth-diminsihing 798 
effect). Data were collected from various studies (1(Knodler et al., 2010), 2(Holzer et al., 799 
2012), 3(Helaine et al., 2010), 4(Claudi et al., 2014), 5(Bowden et al., 2009), 6(Bowden et al., 800 
2014), 7(Garcia-Gutierrez et al., 2016), 8(Singh et al., 2017), 9(Steeb et al., 2013), 10(Bowden 801 
et al., 2010), 11(Tchawa Yimga et al., 2006), 12(Becker et al., 2006), 13(Craig et al., 2013), 802 
14(Popp et al., 2015), 15(Liss et al., 2017), 16(Lathrop et al., 2015), 17(Grant et al., 2012)).  803 
B) Possible supply routes for host nutrients and toxic molecules in Salmonella-infected cells. 804 






Figure 2: Experimental evidence for nutrient supply and enzyme essentiality for Salmonella 809 
during systemic salmonellosis in the mouse typhoid fever model. On top, nutrients are shown 810 
with font size corresponding to differential supply rates. The Salmonella metabolism network 811 
is shown below in a schematic overview with lines (representing enzymes) connecting 812 
symbols (metabolites). Enzymes are shown in different colors that represent enzyme 813 
relevance for Salmonella in vivo fitness. A fully annotated version of this scheme is available 814 
at http://www.biozentrum.unibas.ch/personal/bumann/steeb_et_al/index.html. 815 
